I think this year is going to be a good year
I think this year is going to be a good year
Greggs lady “did you ken there’s a Greggs Diet now?”
Me “oh aye? Does it work?”
Greggs lady “I’d have tae say No. Not if you’re wanting tae lose weight”
#greggs #bakery #Diet #weightloss #healthyeating #newyear #resolution #scotland
Greggs lady “did you ken there’s a Greggs Diet now?”
Me “oh aye? Does it work?”
Greggs lady “I’d have tae say No. Not if you’re wanting tae lose weight”
#greggs #bakery #Diet #weightloss #healthyeating #newyear #resolution #scotland
Do you expect to pick your own pilot when you fly? (To be fair, @mcuban.bsky.social might)
This is how most UHC works. Will Americans be ok with this change to Medicare ?
Referrals for specialist care - NHS share.google/X84C9oCy1rE1...
Do you expect to pick your own pilot when you fly? (To be fair, @mcuban.bsky.social might)
Keir Starmer has decided to only charge inheritance tax to agricultural landowners on estates over £2.5million
However if your only asset is a family home, you start paying inheritance tax at £325,000
What’s the point of this labour government?
Keir Starmer has decided to only charge inheritance tax to agricultural landowners on estates over £2.5million
However if your only asset is a family home, you start paying inheritance tax at £325,000
What’s the point of this labour government?
All tortoises are turtles. But not all turtles are tortoises. Tortoises are real
All tortoises are turtles. But not all turtles are tortoises. Tortoises are real
Every patient I have seen so far admitted with influenza this week is unvaccinated.
The vaccines keep you out of hospital!
Get 💉💉💉
A world with antagonistic AI will generate inequality and injustice and strife and response and progress to the next thing beyond AI
Some questions:
A world with antagonistic AI will generate inequality and injustice and strife and response and progress to the next thing beyond AI
#fashionformen #strongmidsection #mob
#fashionformen #strongmidsection #mob
Health insurance is a deliberately confusing marketplace, and most people can’t be reasonably expected to know what they need
Universal healthcare is the answer to this in every other wealthy country
Health insurance is a deliberately confusing marketplace, and most people can’t be reasonably expected to know what they need
Universal healthcare is the answer to this in every other wealthy country
It’s enough for 10million people to buy a small apartment and live in it
It’s enough for 20million people to get a university education
Nobody benefits from this much concentration of wealth
Malignant capitalism
It’s enough for 10million people to buy a small apartment and live in it
It’s enough for 20million people to get a university education
Nobody benefits from this much concentration of wealth
Malignant capitalism
My hot picks for today:
✅Updated data on #SWOG1801 & #NADINA
✅#SafeStopTrial (early discontinuation of CPI in CR/PR)
✅#STAMP (adj pembro in Merkel Cell)
✅Phase1 #IMA203 for 👁️Uveal Melanoma in Presidential session
@oncoalert.bsky.social @myesmo.bsky.social
My hot picks for today:
✅Updated data on #SWOG1801 & #NADINA
✅#SafeStopTrial (early discontinuation of CPI in CR/PR)
✅#STAMP (adj pembro in Merkel Cell)
✅Phase1 #IMA203 for 👁️Uveal Melanoma in Presidential session
@oncoalert.bsky.social @myesmo.bsky.social
Discussants commented re confirmatory trials in worldwide setting
Is this necessary in 2025? Why don’t we consistently raise this question to EU/US trials?🇪🇺🇺🇸
#oncology #LCSM #oncsky
Discussants commented re confirmatory trials in worldwide setting
Is this necessary in 2025? Why don’t we consistently raise this question to EU/US trials?🇪🇺🇺🇸
#oncology #LCSM #oncsky
🫁Sac-TMT (Trop2 ADC) vs Pt doublet in EGFR mutant #NSCLC 2nd line after targeted therapy
mPFS 8.3 vs 4.3months
mOS Not Reached vs 17.4months
No ILD/pneumonitis. G3 Tox similar in both arms
Exciting option, in a challenging setting
#ESMO25 @oncoalert.bsky.social #LCSM
🫁Sac-TMT (Trop2 ADC) vs Pt doublet in EGFR mutant #NSCLC 2nd line after targeted therapy
mPFS 8.3 vs 4.3months
mOS Not Reached vs 17.4months
No ILD/pneumonitis. G3 Tox similar in both arms
Exciting option, in a challenging setting
#ESMO25 @oncoalert.bsky.social #LCSM
🫁Compared Ivonescimab (PD-1 + VEGF bispecific) vs Tizlelizumab (PD1) in combo ŵ Chemo in 1st line setting for squamous #NSCLC
mPFS = 11.1 vs 6.9 months
Benefit preserved across subgroups including PD-L1<1%
OSdata awaited…
No increase in tox
This data is exciting #ESMO25 @OncoAlert
🫁Compared Ivonescimab (PD-1 + VEGF bispecific) vs Tizlelizumab (PD1) in combo ŵ Chemo in 1st line setting for squamous #NSCLC
mPFS = 11.1 vs 6.9 months
Benefit preserved across subgroups including PD-L1<1%
OSdata awaited…
No increase in tox
This data is exciting #ESMO25 @OncoAlert
Adam Gripping of @mdanderson.bsky.social discusses association of improved OS in #NSCLC and #Melanoma with administration of a mRNA COVID vaccine
Translational work showing mechanism of increased INF-alpha leading to immune priming
Phase III in development… @oncoalert.bsky.social
Adam Gripping of @mdanderson.bsky.social discusses association of improved OS in #NSCLC and #Melanoma with administration of a mRNA COVID vaccine
Translational work showing mechanism of increased INF-alpha leading to immune priming
Phase III in development… @oncoalert.bsky.social
My top picks today are:
🫁 HARMONi6 - Ivonescimab vs PD1 1st line in #NSCLC
🫁OptiTROP-Lung04 - sac-TMT in EGFR
mutant NSCLC post TKI
🩻DREAM3R - Durva+CT 1st line in #Mesothelioma
🏌️ENZARAD (ANZUP 1303) - ADT + RT
#LCSM @oncoalert.bsky.social
My top picks today are:
🫁 HARMONi6 - Ivonescimab vs PD1 1st line in #NSCLC
🫁OptiTROP-Lung04 - sac-TMT in EGFR
mutant NSCLC post TKI
🩻DREAM3R - Durva+CT 1st line in #Mesothelioma
🏌️ENZARAD (ANZUP 1303) - ADT + RT
#LCSM @oncoalert.bsky.social
3year DFS 81% vs 73% for surveillance
Nb increased tox, including myocarditis
#ESMO25 @oncoalert.bsky.social
3year DFS 81% vs 73% for surveillance
Nb increased tox, including myocarditis
#ESMO25 @oncoalert.bsky.social
Today I am looking forward to:
🫁#DeLLphi-303 1st line Tatlatamab in SCLC
🫘#RAMPART from James Larkin on adjuvant IO in RCC
👁️#PLUME Len/Pem in uveal melanoma
⭐️Special Session on PeriOperative strategies from Sapna Patel & others
@myesmo.bsky.social @oncoalert.bsky.social #LCSM
Today I am looking forward to:
🫁#DeLLphi-303 1st line Tatlatamab in SCLC
🫘#RAMPART from James Larkin on adjuvant IO in RCC
👁️#PLUME Len/Pem in uveal melanoma
⭐️Special Session on PeriOperative strategies from Sapna Patel & others
@myesmo.bsky.social @oncoalert.bsky.social #LCSM
Amongst the longest overall survivals reported in lung cancer. Further trials of 3rd and 4th gen TKI ongoing. Much work to do, but valuable to reflect on how far things have com
#ESMO25 #LCSM #Alk #NSCLC
Today looking forward to:
-Session on optimising peri-operative IO from @MartinReck2
-ReCIPE-M1 study from Jacob Orme
-session on emerging options beyond CPI chsired. Y Ines Pires de Silva
-Final ALEX data from Tony Mok and Beamion data from Sanjay Popat
@myesmo.bsky.social
Today looking forward to:
-Session on optimising peri-operative IO from @MartinReck2
-ReCIPE-M1 study from Jacob Orme
-session on emerging options beyond CPI chsired. Y Ines Pires de Silva
-Final ALEX data from Tony Mok and Beamion data from Sanjay Popat
@myesmo.bsky.social